Lachlan Brown
Stock Analyst at William Blair
(0.39)
# 4,025
Out of 4,843 analysts
8
Total ratings
28.57%
Success rate
-15.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lachlan Brown
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KLRS Kalaris Therapeutics | Initiates: Outperform | n/a | $2.90 | - | 1 | Apr 8, 2025 | |
| OCUL Ocular Therapeutix | Initiates: Outperform | n/a | $8.01 | - | 1 | Apr 8, 2025 | |
| SNPS Synopsys | Initiates: Buy | $600 | $463.98 | +29.32% | 1 | Jan 13, 2025 | |
| CDNS Cadence Design Systems | Initiates: Buy | $350 | $287.07 | +21.92% | 1 | Jan 13, 2025 | |
| APLS Apellis Pharmaceuticals | Initiates: Outperform | n/a | $16.93 | - | 1 | Oct 16, 2024 | |
| DSGX The Descartes Systems Group | Initiates: Neutral | $90 | $115.94 | -22.37% | 1 | May 14, 2024 | |
| MANH Manhattan Associates | Initiates: Buy | $260 | $188.78 | +37.73% | 1 | May 14, 2024 | |
| SPSC SPS Commerce | Initiates: Buy | $220 | $140.76 | +56.29% | 1 | May 14, 2024 |
Kalaris Therapeutics
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $2.90
Upside: -
Ocular Therapeutix
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $8.01
Upside: -
Synopsys
Jan 13, 2025
Initiates: Buy
Price Target: $600
Current: $463.98
Upside: +29.32%
Cadence Design Systems
Jan 13, 2025
Initiates: Buy
Price Target: $350
Current: $287.07
Upside: +21.92%
Apellis Pharmaceuticals
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $16.93
Upside: -
The Descartes Systems Group
May 14, 2024
Initiates: Neutral
Price Target: $90
Current: $115.94
Upside: -22.37%
Manhattan Associates
May 14, 2024
Initiates: Buy
Price Target: $260
Current: $188.78
Upside: +37.73%
SPS Commerce
May 14, 2024
Initiates: Buy
Price Target: $220
Current: $140.76
Upside: +56.29%